Skip to content
10-K

Annual Report

EMMAUS LIFE SCIENCES, INC. EMMA

0000950170-25-053744

← back to feed
Filed
Apr 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 25, 2025 63.87M sh
Shares Diluted FY 2024 · Dec 31, 2023 53.11M sh
Capex FY 2024 · Dec 31, 2023 $17K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$1.5M
Cash And Equivalents FY 2024 · Dec 31, 2023 $2.55M
Current Liabilities FY 2024 · Dec 31, 2023 $61.51M
Total Liabilities FY 2024 · Dec 31, 2023 $82.94M
Current Assets FY 2024 · Dec 31, 2023 $11.51M
Total Assets FY 2024 · Dec 31, 2023 $35.18M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.07
Eps Basic FY 2024 · Dec 31, 2023 −$0.07
Sga Expense FY 2024 · Dec 31, 2023 $14.89M
Rd Expense FY 2024 · Dec 31, 2023 $1.19M
Net Income FY 2024 · Dec 31, 2023 −$3.73M
Operating Income FY 2024 · Dec 31, 2023 $3.54M
Gross Profit FY 2024 · Dec 31, 2023 $28.26M
Cost Of Revenue FY 2024 · Dec 31, 2023 $1.34M
Revenue FY 2024 · Dec 31, 2023 $29.6M
Stockholders Equity FY 2024 · Dec 31, 2022 −$34.09M